AKT1 and urinary bladder carcinoma: Its anti-HSV and anti-ADV activities are through inhibition of viral replication, its anti-bladder cancer activity is through the inhibition of androgen signaling pathway, while its anti-prostate cancer activity is through the inhibition of both androgen and AKT signaling pathways [18–21].